These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25554966)

  • 41. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
    Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.
    Adrian G; Carlsson H; Kjellén E; Sjövall J; Zackrisson B; Nilsson P; Gebre-Medhin M
    Radiat Oncol; 2022 Jun; 17(1):107. PubMed ID: 35701827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma.
    Lesinski GB; Nannapaneni S; Griffith CC; Patel M; Chen W; Chen Z; Ahmed R; Wieland A; Shin DM; Chen ZG; Saba NF
    Head Neck Pathol; 2019 Sep; 13(3):304-312. PubMed ID: 30191505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patients.
    Verma V; Liu J; Eschen L; Danieley J; Spencer C; Lewis JS; Diaz J; Piccirillo JF; Adkins DR; Nussenbaum B; Thorstad WL; Gay HA
    Radiat Oncol; 2015 Jan; 10():8. PubMed ID: 25572866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
    Nannapaneni S; Griffith CC; Magliocca KR; Chen W; Lyu X; Chen Z; Wang D; Wang X; Shin DM; Chen ZG; Saba NF
    PLoS One; 2021; 16(2):e0247498. PubMed ID: 33626078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Cohen ER; Reis IM; Gomez C; Pereira L; Freiser ME; Hoosien G; Franzmann EJ
    Otolaryngol Head Neck Surg; 2017 Aug; 157(2):239-251. PubMed ID: 28397583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma.
    Huber GF; Albinger-Hegyi A; Soltermann A; Roessle M; Graf N; Haerle SK; Holzmann D; Moch H; Hegyi I
    Cancer; 2011 Oct; 117(20):4659-70. PubMed ID: 21448927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
    Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition.
    Gurin D; Slavik M; Hermanova M; Shatokhina T; Sana J; Kazda T; Selingerova I; Ahmad P; Smilek P; Horakova Z; Hendrych M; Slampa P; Slaby O
    J Oral Pathol Med; 2018 Oct; 47(9):864-872. PubMed ID: 30079604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 51. The role of tumour morphology in assigning HPV status in oropharyngeal squamous cell carcinoma.
    Molony P; Werner R; Martin C; Callanan D; Nauta I; Heideman D; Sheahan P; Heffron C; Feeley L
    Oral Oncol; 2020 Jun; 105():104670. PubMed ID: 32279011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
    Wang HM; Cheng NM; Lee LY; Fang YH; Chang JT; Tsan DL; Ng SH; Liao CT; Yang LY; Yen TC
    Int J Cancer; 2016 Feb; 138(3):731-8. PubMed ID: 26311121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
    Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor stromal desmoplasia and inflammatory response uniquely predict survival with and without stratification for HPV tumor infection in OPSCC patients.
    Haave H; Gulati S; Brekke J; Lybak S; Vintermyr OK; Aarstad HJ
    Acta Otolaryngol; 2018 Nov; 138(11):1035-1042. PubMed ID: 30734620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
    Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
    Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Tumor Size and p16 Status on Treatment Outcomes - Achievement of Complete Remission in Prospectively Followed Patients with Oropharyngeal Tumors.
    Slavik M; Kazda T; Selingerová I; Šána J; Ahmad P; Gurín D; Hermanová M; Novotný T; Červená R; Dymáčková R; Burkoň P; Slabý O; Šlampa P
    Klin Onkol; 2019; 32(1):58-65. PubMed ID: 30764631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes.
    Barasch S; Mohindra P; Hennrick K; Hartig GK; Harari PM; Yang DT
    Am J Surg Pathol; 2016 Sep; 40(9):1261-9. PubMed ID: 27186851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.
    Holzinger D; Flechtenmacher C; Henfling N; Kaden I; Grabe N; Lahrmann B; Schmitt M; Hess J; Pawlita M; Bosch FX
    Int J Cancer; 2013 Sep; 133(6):1389-99. PubMed ID: 23457055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification.
    Sekimizu M; Ozawa H; Saito S; Ikari Y; Nakahara N; Nakamura S; Yoshihama K; Ito F; Watanabe Y; Imanishi Y; Kameyama K; Ogawa K
    Anticancer Res; 2019 Oct; 39(10):5623-5630. PubMed ID: 31570459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.